Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: CANCER ; GENOME ; PATHWAYS ; THERAPY ; GENE ; BREAST-CANCER ; prognosis ; MUTATION ; DATABASE ; MUTATIONS ; SOMATIC MUTATIONS ; tumours ; Type ; LANDSCAPES ; MYELOID-LEUKEMIA GENOME ; PROJECT ; CANCER-THERAPY ; MANAGEMENT ; SUBTYPES ; REPERTOIRE ; SCIENCE ; development
    Abstract: The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies
    Type of Publication: Miscellaneous publication
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: CANCER MORTALITY ; EXPOSURE ; RISK ; T-CELL ; ASSOCIATION ; LYMPHOMA ; HEALTH ; COUNTRIES ; leukemia ; FOLLICULAR LYMPHOMA ; OCCUPATIONAL EXPOSURE ; NON-HODGKINS-LYMPHOMA ; case-control study ; METAANALYSIS ; HYDROCARBONS ; methods ; SUBTYPES ; B-CELL ; chronic lymphocytic leukaemia ; ORGANIC-SOLVENTS ; BENZENE EXPOSURE ; MULTINATIONAL COHORT ; PETROLEUM WORKERS ; TRICHLOROETHYLENE
    Abstract: Background Several studies have suggested an association between occupational exposure to solvents and lymphoma risk. However, findings are inconsistent and the role of specific chemicals is not known. Objective To investigate the role of occupational exposure to organic solvents in the aetiology of B-cell non-Hodgkin's lymphoma (B-NHL) and its major subtypes, as well as Hodgkin's lymphoma and T-cell lymphoma. Methods 2348 lymphoma cases and 2462 controls participated in a case-control study in six European countries. A subset of cases were reviewed by a panel of pathologists to ensure diagnostic consistency. Exposure to solvents was assessed by industrial hygienists and occupational experts based on a detailed occupational questionnaire. Results Risk of follicular lymphoma significantly increased with three independent metrics of exposure to benzene, toluene and xylene (BTX) (combined p = 4 x 10(-7)) and to styrene (p = 1 x 10(-5)), and chronic lymphocytic leukaemia (CLL) risk increased with exposure to solvents overall (p = 4 x 10(-6)), BTX (p = 5 x 10(-5)), gasoline (p = 8 x 10(-5)) and other solvents (p = 2 x 10(-6)). Risk of B-NHL for ever exposure to solvents was not elevated (OR = 1.1, 95% CI 1.0 to 1.3), and that for CLL and follicular lymphoma was 1.3 (95% CI 1.1 to 1.6) and 1.3 (95% CI 1.0 to 1.7), respectively. Exposure to benzene accounted, at least partially, for the association observed with CLL risk. Hodgkin's lymphoma and T-cell lymphoma did not show an association with solvent exposure. Conclusion This analysis of a large European dataset confirms a role of occupational exposure to solvents in the aetiology of B-NHL, and particularly, CLL. It is suggested that benzene is most likely to be implicated, but we cannot exclude the possibility of a role for other solvents in relation to other lymphoma subtypes, such as follicular lymphoma. No association with risk of T-cell lymphoma and Hodgkin's lymphoma was shown
    Type of Publication: Journal article published
    PubMed ID: 20447988
    Signatur Availability
    BibTip Others were also interested in ...
  • 3
    Keywords: human ; neoplasms ; CLASSIFICATION ; EPIDEMIOLOGY ; NEW-YORK ; RISK ; SAMPLE ; SAMPLES ; INFECTION ; ASSOCIATION ; antibodies ; antibody ; virus ; LYMPHOMA ; ASSAY ; AGE ; LYMPHOCYTES ; case-control studies ; PREVALENCE ; EUROPE ; B-CELL LYMPHOMA ; HUMAN-IMMUNODEFICIENCY-VIRUS ; SERUM ; ADULT ; case-control study ; MALIGNANT-LYMPHOMA ; MIXED CRYOGLOBULINEMIA ; RECIPIENTS ; non-Hodgkin lymphoma ; analysis ; methods ; SUBTYPES ; ASSAYS ; USA ; B-CELL ; MALIGNANT-LYMPHOMAS ; LOW-GRADE ; non Hodgkin lymphoma ; VIRUS CORE PROTEIN ; CONSORTIUM ; red ; INTERLYMPH
    Abstract: Background & Aims: increasing evidence points towards a role of hepatitis C virus (HCV) infection in causing malignant lymphomas. We pooled case-control study data to provide robust estimates of the risk of non-Hodgkin's lymphoma (NHL) subtypes after HCV infection. Methods: The analysis included 7 member studies from the International Lymphoma Epidemiology Consortium (InterLymph) based in Europe, North America, and Australia. Adult cases of NHL (n = 4784) were diagnosed between 1988 and 2004 and controls (n = 6269) were matched by age, sex, and study center. All studies used third-generation enzyme-linked immunosorbent assays to test for antibodies against HCV in serum samples. Participants who were human immunodeficiency virus positive or were organ-transplant recipients were excluded. Results: HCV infection was detected in 172 NHL cases (3.60%) and in 169 (2.70%) controls (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.40 -2.25). In subtype-specific analyses, HCV prevalence was associated with marginal zone lymphoma (OR, 2.47; 95% CI, 1.44-4.23), diffuse large B-cell lymphoma (OR, 2.24; 95% CI, 1.682.99), and lymphoplasmacytic lymphoma (OR, 2.57; 95% CI, 1.14-5.79). Notably, risk estimates were not increased for follicular lymphoma (OR, 1.02; 95% CI, 0.65-1.60). Conclusions: These results confirm the association between HCV infection and NHL and specific B-NHL subtypes (diffuse large B-cell lymphoma, marginal zone lymphoma, and lymphoplasmacytic lymphoma)
    Type of Publication: Journal article published
    PubMed ID: 18387498
    Signatur Availability
    BibTip Others were also interested in ...
  • 4
    Keywords: neoplasms ; EPIDEMIOLOGY ; ASSOCIATION ; NON-HODGKINS-LYMPHOMA ; MATRIX ; REPRODUCTIVE FACTORS ; SUBTYPES ; CHEMICALS ; EPILYMPH ; PESTICIDES
    Abstract: BACKGROUND: Incidence rates of lymphoma are usually higher in men than in women, and oestrogens may protect against lymphoma. METHODS: We evaluated occupational exposure to endocrine disrupting chemicals (EDCs) among 2457 controls and 2178 incident lymphoma cases and subtypes from the European Epilymph study. RESULTS: Over 30 years of exposure to EDCs compared to no exposure was associated with a 24% increased risk of mature B-cell neoplasms (P-trend=0.02). Associations were observed among men, but not women. CONCLUSIONS: Prolonged occupational exposure to endocrine disruptors seems to be moderately associated with some lymphoma subtypes.
    Type of Publication: Journal article published
    PubMed ID: 25742473
    Signatur Availability
    BibTip Others were also interested in ...
  • 5
    Keywords: CANCER ; CELLS ; neoplasms ; CT ; INFORMATION ; EPIDEMIOLOGY ; POPULATION ; RISK ; RISKS ; SAMPLE ; SAMPLES ; IDENTIFICATION ; LYMPHOMA ; HEALTH ; WOMEN ; hair dyes ; UNITED-STATES ; case-control studies ; non-Hodgkin lymphoma ; SUBTYPES ; USA ; N-ACETYLTRANSFERASE-1 ; non Hodgkin lymphoma ; non-Hodgkin ; CONSORTIUM ; N-ACETYLATION ; PHENYLENEDIAMINE
    Abstract: Personal use of hair dye has been inconsistently linked to risk of non-Hodgkin lymphoma (NHL), perhaps because of small samples or a lack of detailed information on personal hair-dye use in previous studies. This study included 4,461 NHL cases and 5,799 controls from the International Lymphoma Epidemiology Consortium 1988-2003. Increased risk of NHL (odds ratio (OR) = 1.3, 95% confidence interval (CI): 1.1, 1.4) associated with hair-dye use was observed among women who began using hair dye before 1980. Analyses by NHL subtype showed increased risk for follicular lymphoma (FL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) but not for other NHL subtypes. The increased risks of FL (OR = 1.4, 95% CI: 1.1, 1.9) and CLL/SLL (OR = 1.5, 95% CI: 1.1, 2.0) were mainly observed among women who started using hair dyes before 1980. For women who began using hair dye in 1980 or afterward, increased FL risk was limited to users of dark-colored dyes (OR = 1.5, 95% CI: 1.1, 2.0). These results indicate that personal hair-dye use may play a role in risks of FL and CLL/SLL in women who started use before 1980 and that increased risk of FL among women who started use during or after 1980 cannot be excluded
    Type of Publication: Journal article published
    PubMed ID: 18408225
    Signatur Availability
    BibTip Others were also interested in ...
  • 6
    Keywords: RISK ; COMPLEX ; COMPLEXES ; ASSOCIATION ; POLYMORPHISMS ; SUSCEPTIBILITY ; VARIANTS ; LYMPHOMA ; genetics ; HLA ; FOLLICULAR LYMPHOMA ; VARIANT ; HIGH-RESOLUTION ; non-Hodgkin lymphoma ; SUBTYPES ; HAPLOTYPE ; LOCUS ; LOCI ; susceptibility loci ; NON-HODGKIN-LYMPHOMA ; GENOME-WIDE ASSOCIATION ; GENETIC-VARIATION ; non-Hodgkin ; Genetic ; NECROSIS-FACTOR TNF
    Abstract: To identify susceptibility loci for non-Hodgkin lymphoma subtypes, we conducted a three-stage genome-wide association study. We identified two variants associated with follicular lymphoma at 6p21.32 (rs10484561, combined P = 1.12 x 10(-29) and rs7755224, combined P = 2.00 x 10(-19); r(2) = 1.0), supporting the idea that major histocompatibility complex genetic variation influences follicular lymphoma susceptibility. We also found confirmatory evidence of a previously reported association between chronic lymphocytic leukemia/small lymphocytic lymphoma and rs735665 (combined P = 4.24 x 10(-9))
    Type of Publication: Journal article published
    PubMed ID: 20639881
    Signatur Availability
    BibTip Others were also interested in ...
  • 7
    Keywords: Germany ; COHORT ; RISK ; RISK-FACTORS ; ASSOCIATION ; LYMPHOMA ; AGE ; CIGARETTE-SMOKING ; etiology ; MEN ; smoking ; COUNTRIES ; RECRUITMENT ; UNITED-STATES ; case-control studies ; TOBACCO ; ALCOHOL ; CONSUMPTION ; EUROPE ; non-hodgkin's lymphoma ; MULTICENTER ; MULTIPLE-MYELOMA ; OLDER WOMEN ; case-control study ; RE ; case control studies ; SUBTYPES ; pooled analysis ; CANCER-MORTALITY ; MULTICENTER CASE-CONTROL ; non-Hodgkin's
    Abstract: To study the role of tobacco smoking and alcohol drinking in the etiology of non-Hodgkin's lymphoma (NHL), we conducted a multicenter case-control study in Spain, France, Germany, Italy, Ireland and Czech Republic between 1998 and 2004, which included 1,742 cases of NHL and 2,465 controls matched on age, sex and recruitment area. Tobacco smoking was not associated with the risk of NHL overall or with risk of specific histological subtypes. Similarly, there was no association between alcohol drinking and the risk of NHL overall or across histological subtypes. However. a protective effect of alcohol drinking was observed among men (OR = 0.76, 95% CI = 0.62-0.93) and in non-Mediterranean countries (OR = 0.73, 95% CI = 0.61-0.86). There was no evidence of interaction between alcohol drinking and tobacco smoking in NHL etiology. The results of this large-scale European study did not support an association between tobacco and NHL and suggested a protective effect of alcohol on development of NHL for men and in non-Mediterranean countries. (c) 2006 Wiley-Liss. Inc
    Type of Publication: Journal article published
    PubMed ID: 16557575
    Signatur Availability
    BibTip Others were also interested in ...
  • 8
    Keywords: Germany ; human ; MODEL ; EXPOSURE ; HEPATOCELLULAR-CARCINOMA ; HISTORY ; RISK ; RNA ; INFECTION ; FAMILY ; T cell ; T-CELL ; ASSOCIATION ; POLYMORPHISMS ; virus ; LYMPHOMA ; MALIGNANCIES ; AGE ; family history ; etiology ; COUNTRIES ; leukemia ; PATHOGENESIS ; REPLICATION ; case-control studies ; INDIVIDUALS ; PREVALENCE ; INTERVIEW ; MULTICENTER ; B-CELL LYMPHOMA ; immunoassay ; NON-HODGKINS-LYMPHOMA ; SERUM ; MALIGNANCY ; case-control study ; RE ; FAMILIES ; VIRUS-INFECTION ; LYMPHOPROLIFERATIVE DISORDERS ; MIXED CRYOGLOBULINEMIA ; METAANALYSIS ; case control studies ; INTERVAL ; ENZYME ; SUBTYPES ; LYMPHOMAS ; SIZE ; FAMILY-HISTORY ; EUROPEAN COUNTRIES ; odds ratio ; B-CELL ; EXPOSURES ; MULTICENTER CASE-CONTROL ; RARE ; SAMPLE-SIZE ; HCV INFECTION
    Abstract: Background & Aims: Increasing evidence points toward a role of hepatitis C virus (HCV) infection in the etiology of malignant lymphomas. However, previous epidemiologic studies were limited in size to establish an association between HCV infection and specific lymphoma subtypes. We performed a large, multicenter, case-control study to address this question. Methods: The study comprised 5 European countries and included newly diagnosed cases of any lymphoid malignancy recruited between 1998 and 2004. Controls were matched to cases by 5-year age group, sex, and study center. In-person interviews were conducted to collect data on demographic, medical, and family history as well as environmental exposures. Serum samples of 1807 cases and 1788 controls (excluding human immunodeficiency virus-positive and organ-transplantation subjects) were screened for HCV infection using an enzyme immunoassay. Positive as well as randomly selected negative samples were subjected to HCV RNA detection and HCV genotyping. Results: HCV infection was detected in 53 (2.9%) lymphoma cases and in 41 (2.3%) control subjects (odds ratio [OR], 1.42; 95% confidence interval [CI]: 0.93-2.15). Restricted to individuals who tested positive for HCV-RNA (indicating persistent infection and active viral replication), the OR was 1.82 (95% CI: 1.13-2.91). In subtype-specific analyses, HCV prevalence was associated with diffuse large B-cell lymphoma (OR, 2.19; 95% CI: 1.23-3.91) but not with chronic lymphocytic leukemia or follicular, Hodgkin's, or T-cell lymphoma. The sample size was not sufficient to derive any conclusions for rare lymphoma entities such as splenic marginal zone lymphoma. Conclusions: These results support a model that chronic HCV replication contributes to lymphomagenesis and establish a specific role of HCV infection in the pathogenesis of diffuse large B-cell lymphoma
    Type of Publication: Journal article published
    PubMed ID: 17087949
    Signatur Availability
    BibTip Others were also interested in ...
  • 9
    Keywords: BLOOD ; MODEL ; DISEASE ; RISK ; PATIENT ; ARTHRITIS ; RISK-FACTORS ; T cell ; T-CELL ; TYPE-1 ; ASSOCIATION ; DISORDER ; LYMPHOMA ; risk factors ; SWEDEN ; diabetes ; case-control studies ; CLUES ; MULTIPLE-SCLEROSIS ; FOLLICULAR LYMPHOMA ; INFLAMMATORY-BOWEL-DISEASE ; SYSTEMIC-LUPUS-ERYTHEMATOSUS ; DISORDERS ; case-control study ; MEDICAL HISTORY ; POPULATION-BASED COHORT ; PATTERN ; T-CELL LYMPHOMA ; rheumatoid arthritis ; RHEUMATOID-ARTHRITIS ; non-Hodgkin lymphoma ; analysis ; SUBTYPES ; CELIAC-DISEASE ; PARTICIPANTS ; multiple sclerosis ; pooled analysis ; USA ; CANCER INCIDENCE ; RISK-FACTOR ; B-CELL ; ANEMIA ; PERNICIOUS-ANEMIA ; systemic ; RATIO ; non Hodgkin lymphoma ; POOLED-ANALYSIS ; non-Hodgkin ; CONSORTIUM ; CONFIDENCE-INTERVALS ; MARGINAL ZONE LYMPHOMAS ; INTERLYMPH ; AUTOIMMUNE ; HEMATOPOIETIC CANCER ; hemolytic anemia ; PRIMARY SJOGRENS-SYNDROME ; systemic lupus erythematosus
    Abstract: Some autoimmune disorders are increasingly recognized as risk factors for non-Hodgkin lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes are lacking. We performed a pooled analysis of self-reported autoimmune conditions and risk of NHL and subtypes, including 29 423 participants in 12 case-control studies. We computed pooled odds ratios (OR) and 95% confidence intervals (CI) in a joint fixed-effects model. Sjogren syndrome was associated with a 6.5-fold increased risk of NHL, a 1000-fold increased risk of parotid gland marginal zone lymphoma (OR = 996; 95% CI, 216-4596), and with diffuse large B-cell and follicular lymphomas. Systemic lupus erythematosus was associated with a 2.7-fold increased risk of NHL and with diffuse large B-cell and marginal zone lymphomas. Hemolytic anemia was associated with diffuse large B-cell NHL. T-cell NHL risk was increased for patients with celiac disease and psoriasis. Results for rheumatoid arthritis were heterogeneous between studies. Inflammatory bowel disorders, type 1 diabetes, sarcoidosis, pernicious anemia, and multiple sclerosis were not associated with risk of NHL or subtypes. Thus, specific autoimmune disorders are associated with NHL risk beyond the development of rare NHL subtypes in affected organs. The pattern of associations with NHL subtypes may harbor clues to lymphomagenesis
    Type of Publication: Journal article published
    PubMed ID: 18263783
    Signatur Availability
    BibTip Others were also interested in ...
  • 10
    Keywords: CANCER ; MODEL ; SUPPORT ; EPIDEMIOLOGY ; LONG-TERM ; RISK ; COMPONENTS ; ASSOCIATION ; NO ; LYMPHOMA ; WOMEN ; MEN ; OBESITY ; UNITED-STATES ; case-control studies ; ALCOHOL-CONSUMPTION ; nutrition ; B-CELL LYMPHOMA ; ONCOLOGY ; case-control study ; REGRESSION ; MALIGNANT-LYMPHOMA ; WEIGHT ; PHYSICAL-ACTIVITY ; HEIGHT ; non-Hodgkin lymphoma ; analysis ; diffuse large B-cell lymphoma ; SUBTYPES ; BODY-MASS INDEX ; pooled analysis ; OVERWEIGHT ; USA ; BMI ; RISK-FACTOR ; CANCER-RISK ; B-CELL ; ENGLAND ; RATIO ; non Hodgkin lymphoma ; EXCESS ; POOLED-ANALYSIS ; NO EVIDENCE ; non-Hodgkin ; CONSORTIUM ; nutritional status ; INTERLYMPH ; body mass index weight ; FORMER COLLEGE-STUDENTS ; LYMPHOHEMATOPOIETIC MALIGNANCIES ; SCANDINAVIAN MEN
    Abstract: Nutritional status is known to alter immune function, a suspected risk factor for non-Hodgkin lymphoma (NHL). To investigate whether long-term over, or under, nutrition is associated with NHL, self-reported anthropometric data on weight and height from over 10,000 cases of NHL and 16,000 controls were pooled across 18 case-control studies identified through the International Lymphoma Epidemiology Consortium. Study-specific odds ratios (OR) were estimated using logistic regression and combined using a random-effects model. Severe obesity, defined as BMI of 40 kg m(-2) or more, was not associated with NHL overall (pooled OR = 1.00, 95% confidence interval (CI) 0.70-1.41) or the majority of NHL subtypes. An excess was however observed for diffuse large B-cell lymphoma (pooled OR = 1.80, 95% CI 1.24-2.62), although not all study-specific ORs were raised. Among the overweight (BMI 25-29.9 kg m(-2)) and obese (BMI 30-39.9 kg m(-2)), associations were elevated in some studies and decreased in others, while no association was observed among the underweight (BMI 〈 18.5 kg m(-2)). There was little suggestion of increasing ORs for NHL or its subtypes with every 5 kg m(-2) rise in BMI above 18.5 kg m(-2). BMI components height and weight were also examined, and the tallest men, but not women, were at marginally increased risk (pooled OR = 1.19, 95% CI 1.06-1.34). In summary, whilst we conclude that there is no evidence to support the hypothesis that obesity is a determinant of all types of NHL combined, the association between severe obesity and diffuse large B-cell lymphoma may warrant further investigation. (C) 2007 Wiley-Liss, Inc
    Type of Publication: Journal article published
    PubMed ID: 18167059
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...